Compare Ancora Indonesia Resources Tbk. (OKAS) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ancora Indonesia Resources Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Ancora Indonesia Resources Tbk. trades at Rp116 (market cap 280.07B, 3.46M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Ancora Indonesia Resources Tbk. is far larger — about 2.7× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| OKAS | SCPI | |
|---|---|---|
Market Cap | 280.07B | 104.4B |
Volume | 3.46M | — |
Lot | 34.59K | — |
Turnover | 403.59M | — |
Average Price | 116.69 | — |
Value | 403.59M | — |
Indicative Equilibrium Price | 116 | — |
Indicative Equilibrium Volume | 567 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ancora Indonesia Resources Tbk.
PT Ancora Indonesia Resources Tbk (the Company) was establised on September 15, 2003. Based to the Extraordinary General Meeting of Shareholders,all shareholders approved the change of the Company's name from PT TD Resources Tbk to PT Ancora Indonesia Resources Tbk. This change of the Company's name was effective on December 3, 2008.
Read more on OKAS →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
